Genset/Abbott alliance will co-promote "pharmacogenomics" services to pharmaceutical industry.
Executive Summary
GENSET AND ABBOTT TO CO-PROMOTE "PHARMACOGENOMICS" SERVICES to other pharmaceutical companies under an agreement announced July 28. The firms characterized pharmacogenomics as an approach to drug discovery and disease management that is based on a whole "genome analysis that...deciphers the global basis for individual drug response."